Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Gross Profit | N/A | N/A | N/A | -2 | N/A |
| Operating Expenses | 9,209 | 6,892 | 7,999 | 6,380 | 5,966 |
| Operating Income | -9,209 | -6,892 | -7,999 | -6,380 | -5,966 |
| Other Income | -20,134 | -1,079 | 3,801 | 80 | 34 |
| Pre-tax Income | -29,343 | -7,971 | -4,198 | -6,300 | -5,932 |
| Income Tax | 55 | 41 | 19 | 10 | 14 |
| Net Income Continuous | -29,398 | -8,012 | -4,217 | -6,137 | -5,946 |
| Net Income | $-29,398 | $-8,012 | $-4,217 | $-6,136 | $-5,946 |
| EPS Basic Total Ops | -2.95 | -0.80 | -0.42 | -1.00 | -0.93 |
| EPS Basic Continuous Ops | -2.95 | -0.80 | -0.42 | -0.78 | -0.93 |
| EPS Diluted Total Ops | -2.95 | -0.80 | -0.42 | -1.00 | -0.93 |
| EPS Diluted Continuous Ops | -2.95 | -0.80 | -0.42 | -0.78 | -0.93 |
| EBITDA(a) | $-9,168 | $-6,850 | $-7,977 | $-6,358 | $-5,936 |